Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 33, Issue 9, 2018, Pages 1590-1597

  Hirano, Atsushi ^a   Umeno, Junji ^a   Okamoto, Yasuharu ^a   Shibata, Hiroki ^b   Ogura, Yoshitoshi ^a   Moriyama, Tomohiko ^a   Torisu, Takehiro ^a   Fujioka, Shin ^a   Fuyuno, Yuta ^a   Kawarabayasi, Yutaka ^c   Matsumoto, Takayuki ^d   Kitazono, Takanari ^a   Esaki, Motohiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

16S rRNA gene sequence; dysbiosis; mucosal microbiota; ulcerative colitis

Indexed keywords

MESALAZINE; PROBIOTIC AGENT; RNA 16S;

ADULT; AGED; ARTICLE; BACTERIUM; BILOPHILA; BUTYRICIMONAS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DESULFOVIBRIO; EUBACTERIUM; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; LEPTOTRICHIA; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROFLORA; NEISSERIA; NEXT GENERATION SEQUENCING; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; PROCTITIS; SOFTWARE; ULCERATIVE COLITIS;

EID: 85044313158     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.14129     Document Type: Article

References (38)

1. Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008; 3: e2836
2. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 2016; 375: 2369–2379
3. Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 2017; 152: 327–339. e4
4. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014; 146: 1489–1499
5. Becker C, Neurath MF, Wirtz S. The intestinal microbiota in inflammatory bowel disease. ILAR J. 2015; 56: 192–204
6. Pascal V, Pozuelo M, Borruel N et al. A microbial signature for Crohn's disease. Gut. 2017; 66: 813–822
7. Halfvarson J, Bodin L, Tysk C, Lindberg E, Järnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767–1773
8. Momozawa Y, Deffontaine V, Louis E, Medrano JF. Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS One 2011; 6: e16952
9. Lavelle A, Lennon G, O'Sullivan O et al. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut. 2015; 64: 1553–1561
10. Sartor RB. Gut microbiota: optimal sampling of the intestinal microbiota for research. Nat. Rev. Gastroenterol. Hepatol. 2015; 12: 253–254
11. Sepehri S, Kotlowski R, Bernstein CN, Krause DO. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 2007; 13: 675–683
12. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J. Med. Microbiol. 2006; 55: 1141–1149
13. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 2006; 44: 4136–4141
14. Walker AW, Sanderson JD, Churcher C et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011; 11: 7
15. Forbes JD, Van Domselaar G, Bernstein CN. Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflamm. Bowel Dis. 2016; 22: 817–825
16. Caporaso JG, Lauber CL, Walters WA et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012; 6: 1621–1624
17. Caporaso JG, Kuczynski J, Stombaugh J et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010; 7: 335–336
18. DeSantis TZ, Hugenholtz P, Larsen N et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006; 72: 5069–5072
19. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26: 2460–2461
20. Haas BJ, Gevers D, Earl AM et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011; 21: 494–504
21. Segata N, Izard J, Waldron L et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 12: R60
22. Afgan E, Baker D, van den Beek M et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016; 44: W3–W10
23. Allen TD, Lawson PA, Collins MD, Falsen E, Tanner RS. Cloacibacterium normanense gen. nov., sp. nov., a novel bacterium in the family Flavobacteriaceae isolated from municipal wastewater. Int. J. Syst. Evol. Microbiol. 2006; 56: 1311
24. Chiodini RJ, Dowd SE, Chamberlin WM, Galandiuk S, Davis B, Glassing A. Microbial population differentials between mucosal and submucosal intestinal tissues in advanced Crohn's disease of the ileum. PLoS One 2015; 10: e0134382
25. Alauzet C, Marchandin H, Courtin P et al. Multilocus analysis reveals diversity in the genus Tissierella: description of Tissierella carlieri sp. nov. in the new class Tissierellia classis nov. Syst. Appl. Microbiol. 2014; 37: 23–34
26. Hill-Burns EM, Debelius JW, Morton JT et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov. Disord. 2017
27. Atarashi K, Tanoue T, Oshima K et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232–236
28. Vermeiren J, Van den Abbeele P, Laukens D et al. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol. Ecol. 2012; 79: 685–696
29. Knoll RL, Forslund K, Kultima JR et al. Gut microbiota differs between children with inflammatory bowel disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Am. J. Physiol. Gastrointest. Liver Physiol. 2017; 312: G327–G339
30. Jangi S, Gandhi R, Cox LM et al. Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 2016; 7: 12015
31. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 2010; 107: 14691–14696
32. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105–108
33. Said HS, Suda W, Nakagome S et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res. 2014; 21: 15–25
34. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559–563
35. Earley H, Lennon G, Balfe A et al. A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS One 2015; 10: e0135280
36. Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE. Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J. Clin. Microbiol. 2012; 50: 1228–1232
37. Kato K, Mizuno S, Umesaki Y et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 2004; 20: 1133–1141
38. Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm. Bowel Dis. 2005; 11: 481–487